Read More

Chamath Palihapitiya Launches 4 New Biotech SPACs: What Investors Should Know

One of the most famous voices in the SPAC industry is launching four new SPACs and also making several changes to his existing lineup of SPACs and former SPACs. What Happened: Chamath Palihapitiya is launching four new SPACs targeting the biotechnology sector. Each SPAC is seeking to raise $200 million and will not contain warrants.

CLOV

Read More

Where Could Clover Health Go In The Coming Weeks?

Clover Heath Investments Corp. (NASDAQ: CLOV) shares are trading lower Wednesday morning. The share price has fallen throughout the past week, the drop is potentially due to Lifshitz Law Firm announcing on May 2 the firm is going to start an investigation of Clover Health.

CLOV